Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 May 12;72(19):536-537.
doi: 10.15585/mmwr.mm7219a4.

Notes from the Field: First Reported U.S. Cases of Tinea Caused by Trichophyton indotineae - New York City, December 2021-March 2023

Case Reports

Notes from the Field: First Reported U.S. Cases of Tinea Caused by Trichophyton indotineae - New York City, December 2021-March 2023

Avrom S Caplan et al. MMWR Morb Mortal Wkly Rep. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Figures

FIGURE
FIGURE
Lesions occurring on two patients with first reported U.S. cases of tinea caused by Trichophyton indotineae, on patient A’s neck, abdomen, and buttocks (A–C) and on patient B’s thighs (D) — New York City, December 2021–March 2023 Photos/Lu Yin (A–C) and Vignesh Ramachandran (D). Used with patients’ permission. At initial dermatology evaluation, patient A had large, annular, scaly, and pruritic erythematous plaques of the neck, abdomen, groin, and buttocks. At initial dermatology evaluation, patient B had widespread, discrete, scaly, annular, pruritic plaques affecting the thighs and buttocks.

References

    1. Gupta AK, Venkataraman M, Hall DC, Cooper EA, Summerbell RC. The emergence of Trichophyton indotineae: implications for clinical practice. Int J Dermatol 2022. Epub July 22, 2023. 10.1111/ijd.16362 - DOI - PubMed
    1. Verma SB, Panda S, Nenoff P, et al. The unprecedented epidemic-like scenario of dermatophytosis in India: II. diagnostic methods and taxonomical aspects. Indian J Dermatol Venereol Leprol 2021;87:326–32. 10.25259/IJDVL_302_20 - DOI - PubMed
    1. Uhrlaß S, Verma SB, Gräser Y, et al. Trichophyton indotineae–an emerging pathogen causing recalcitrant dermatophytoses in India and worldwide–a multidimensional perspective. J Fungi (Basel) 2022;8:757. 10.3390/jof8070757 - DOI - PMC - PubMed
    1. Burmester A, Hipler UC, Uhrlaß S, et al. Indian Trichophyton mentagrophytes squalene epoxidase erg1 double mutants show high proportion of combined fluconazole and terbinafine resistance. Mycoses 2020;63:1175–80. 10.1111/myc.13150 - DOI - PubMed
    1. Khurana A, Agarwal A, Agrawal D, et al. Effect of different itraconazole dosing regimens on cure rates, treatment duration, safety, and relapse rates in adult patients with tinea corporis/cruris: a randomized clinical trial. JAMA Dermatol 2022;158:1269–78. 10.1001/jamadermatol.2022.3745 - DOI - PMC - PubMed

Publication types